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Peripheral arterial disease (PAD) often refers to atherosclerot-
ic blockages found in the lower extremities and is a spectrum 
of macrovascular complications found in patients with type 2 
diabetes. The same risk factors that contribute to coronary ar-
tery disease (CAD) and cerebrovascular disease (CVD) also 
lead to the development of PAD. These vascular conditions of-
ten coexist in patients, increasing the risk for developing isch-
emic events such as myocardial infarction and stroke. Also, 
PAD patients without clinical evidence of CAD have the same 
relative risk of death from cardiac or cerebrovascular causes as 
those diagnosed with prior CAD, consistent with the systemic 
nature of the disease [1]. Nearly 50% of all patients with PAD 
are asymptomatic, and PAD in these patients is often detected 
by measuring the ankle-brachial index (ABI), which is the ra-
tio of the highest systolic blood pressure (SBP) in the dorsalis 
pedis or posterior tibial artery of each leg to that of the highest 
SBP in the brachial artery of the arms. The ABI has 95% sensi-
tivity and 99% specificity for the detection of PAD [2]. 
  In a recent issue of Diabetes & Metabolism Journal, Yu et al. 
[3] presented an article regarding the prevalence of PAD in 
Korean patients with type 2 diabetes. The authors reported 
that 3.2% of Korean diabetic patients attending a university 
hospital were diagnosed as having PAD, and the presence of 
microvascular and/or macrovascular complications was inde-
pendently associated with PAD. Their study is one of a few re-
porting the prevalence of PAD in Korean type 2 diabetic pa-
tients and is an interesting paper that addresses the association 
between PAD and microvascular and/or macrovascular com-
plications. 
  First, as the authors of that study mentioned, the prevalence 
of PAD in their study (3.2%; mean age, 67 years; duration of 
diabetes, 12.9 years), that of PAD in a previous nationwide 
survey performed by the Committee of the Korean Diabetes 
Association on the Epidemiology of Diabetes Mellitus (3%; 
mean age, 59 years; duration of diabetes, 8.8 years) and that of 
PAD in the Korean National Diabetes Program [4] (1.1%; mean 
age, 54 years; duration of diabetes, 6.0 years) were consider-
ably lower than those in the United States, Germany, and Chi-
na (22 to 32%; mean age, 60 to 73 years; duration of diabetes, 
6.0 to 7.2 years). The age and duration of diabetes in Korean 
participants were not younger or shorter than those in West-
ern or Chinese populations. However, the prevalence of PAD 
in Japan or India (7.6% and 6.3%, respectively) were as low as 
that in Korea [5,6]. We cannot determine whether this effect is 
specific to Asians because the prevalence of PAD in China was 
high.
  Second, although an ABI of less than 0.9 is the most com-
monly used value to denote PAD, it should be recognized that 
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individuals with an ABI between 0.90 and 0.99 have higher 
morbidity and mortality compared with those in people with a 
normal ABI range [7]. On the other hand, an ABI value great-
er than 1.3/1.4 or incompressible arteries at ankle level suggest 
the presence of medial arterial calcification (MAC), which 
usually affects medium- to small-sized muscular arteries in di-
abetic patients, especially in the lower limbs, and shows histo-
logical calcification in the medial arterial wall, instead of the 
intimal calcification found in atheromatous arterial disease 
[8]. This finding renders the diagnosis of PAD by an ABI mea-
surement unreliable. In the Strong Heart Study, cardiovascular 
mortality over an 8-year follow-up period was significantly 
higher in subjects with an initial ABI <0.9 or >1.4 compared 
with that of normal ABI subjects. The U-shaped association 
between ABI and cardiovascular mortality correlated with the 
increased prevalence of diabetes and hypertension in both low 
and high ABI groups [9]. Both high (>1.4 or noncompressible) 
and low ABIs (<0.9) have been closely associated with chronic 
kidney disease [10]. The subanalysis of a group with borderline 
ABI values (0.90 to 0.99) would help to provide insight on the 
association between PAD and atherosclerotic complications. 
Also, we wonder why subjects with high ABI (>1.4) accounted 
for only 0.7% of the study population because several studies 
have shown that the prevalence of MAC in patients with type 
2 diabetes is not small [11,12].
  Third, because central pulse wave velocity (PWV) values 
could not be measured by a VP-1000 device, only baPWV 
measurements between groups with or without PAD among 
PWV segments were shown in this study. However, increased 
aortic PWV is regarded as subclinical target damage. A recent 
study demonstrated that arterial stiffness values in different 
regions may have different roles in cardiovascular disease and 
showed that, among the central PWV and peripheral PWV 
measurements, elevated aortic PWV was most closely associ-
ated with coronary, cerebral, peripheral arterial disease and 
chronic kidney disease [13,14]. Also, baPWV measurements 
are known to not be reliable in patients with ABI <0.9.
  This study by Yu and colleagues is a clinically important 
work showing the ethnic differences in the prevalence of PAD 
in Korea compared those in Western or Chinese populations. 
Additional large sample and sophisticated, long-term prospec-
tive cohort studies directly comparing clinical outcomes, such 
as symptoms of PAD, foot ulcers, amputation or cardiovascu-
lar morbidity or mortality and a survey of medications, are 
warranted. Finally, we greatly appreciate the devotion of the 
study investigators to reveal such important clinical data and 
wish them continued success in their future study. 
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